...
首页> 外文期刊>Medical hypotheses >Hypothermic preconditioning of donor organs prior to harvesting and ischaemia using ice-cold intravenous fluids.
【24h】

Hypothermic preconditioning of donor organs prior to harvesting and ischaemia using ice-cold intravenous fluids.

机译:使用冰冷的静脉注射液对供体器官进行低温预处理,然后进行收获和局部缺血。

获取原文
获取原文并翻译 | 示例
           

摘要

To promote organ transplantation and viability, hypothermia has been applied as a protective agent for decades. Current management of organ preservation includes hypothermia as a component of static storage. In rare cases, hypothermic perfusion is initiated in the donor organs prior to harvesting but this requires invasive perfusion techniques. Therefore, hypothermic organ protection is currently achieved only after organ retrieval and onset of ischaemic injury cascades. The relevant mechanisms of cellular and organ damage involve ischaemia-reperfusion injury and apoptosis. In this hypothesis, we propose the possibility of inducing hypothermic protective effects prior to organ harvesting using infusion of ice-cold (+4 degrees C) intravenous fluid in the organ donor. This method of cooling to mild hypothermia (32-34 degrees C) has been found feasible in e.g. cardiac arrest victims and already during the ischaemic insult. We hypothesize that cooling with ice-cold fluid preceding organ harvesting would downregulate organ metabolism and oxygen consumption resulting in improved tolerance to ischaemia. Furthermore, according to existing evidence, mild hypothermia possesses anti-apoptotic effects and suppresses reperfusion associated inflammatory response. Finally, diabetes insipidus is often observed in the brain dead donor. Subsequent hypovolemia is conveniently treated with additional infusion of cold intravenous fluid. We offer this hypothesis as a simple method of improving donor organ viability via improved tolerance to ischaemia and reperfusion injury. This method of hypothermic preconditioning seems safe, inexpensive and easily applicable in virtually every institution treating organ donors. The feasibility and effects of this hypothesis could be further evaluated in comparison to current treatment protocols in laboratory settings including evaluation of organ preservation.
机译:为了促进器官移植和生存能力,低温治疗已被用作保护剂已有数十年的历史了。当前器官保存的管理包括将低温作为静态存储的一部分。在极少数情况下,在收获前先在供体器官中进行低温灌注,但这需要侵入性灌注技术。因此,目前仅在器官恢复和缺血性损伤级联发作后才实现低温器官保护。细胞和器官损伤的相关机制涉及缺血-再灌注损伤和细胞凋亡。在该假设中,我们提出了在器官供体中注入冰冷(+4摄氏度)静脉注射的液体,在器官收获前诱导低温保护作用的可能性。已经发现这种冷却至轻度低温(32-34℃)的方法是可行的。心脏骤停的受害者,并且已经在缺血性损伤中。我们假设在器官收获前用冰冷的液体冷却会降低器官的新陈代谢和耗氧量,从而提高了对缺血的耐受性。此外,根据现有证据,温和的低温具有抗凋亡作用,并抑制与再灌注相关的炎症反应。最后,经常在脑死亡的供体中观察到尿崩症。随后的血容量不足可以通过额外输注冷静脉注射液来方便地治疗。我们提供这一假设是通过提高对缺血和再灌注损伤的耐受性来提高供体器官生存力的简单方法。低温预热的这种方法似乎安全,便宜且易于在几乎所有治疗器官供体的机构中使用。与实验室设置中的当前治疗方案(包括评估器官保存)相比,可以进一步评估该假设的可行性和影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号